We are live on ! Find out more
DOFI

DCVC Opportunity Fund II Portfolio holdings

AUM $13.9M
1-Year Est. Return 8.04%
This Fund
S&P 500
This Quarter Est. Return
+81.95%
1 Year Est. Return
+8.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
+$33.8M
Cap. Flow
-$17.7M
Cap. Flow %
-15.4%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RKLB icon
Rocket Lab Corp
RKLB
+$17.7M

Sector Composition

Rank Sector Weight
1 Industrials 82.65%
2 Healthcare 17.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RKLB icon
1
Rocket Lab Corp
RKLB
$39.9B
$95.3M 82.65%
2,663,139
-725,110
-21% -$17.7M
RXRX icon
2
Recursion Pharmaceuticals
RXRX
$1.57B
$20M 17.35%
3,951,141

Similar funds

DCVC Opportunity Fund II's Q2 2025 Portfolio in Review

As of Q2 2025, DCVC Opportunity Fund II held 2 positions worth $115M, up 41% from $81.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

DCVC Opportunity Fund II withdrew a net $17.7M in Q2 2025, reducing 1 holding. Its largest reduction was Rocket Lab Corp, cutting an estimated $17.7M.

By sector, the portfolio is most concentrated in Industrials at 83% of assets, up from 74% a quarter earlier, followed by Healthcare.

  • DCVC Opportunity Fund II's biggest Q2 2025 reduction was Rocket Lab Corp, cutting an estimated $17.7M.
  • DCVC Opportunity Fund II's ten largest holdings make up 100% of its $115M portfolio in Q2 2025.
  • DCVC Opportunity Fund II opened 0 new positions and closed 0 in Q2 2025.
  • DCVC Opportunity Fund II's portfolio value rose 41% quarter-over-quarter to $115M.

Based on DCVC Opportunity Fund II's 13F filing for Q2 2025, filed 14 Aug 2025.